Pharmaceutical companies in the West and their host governments are very confident today, and some even speak of “post crisis investing”. Certainly, pharma’s scientific credentials have been demonstrated and the public in the UK and the US in particular are seeing the potential end to lockdowns.
Already an IPE Member? Sign in here
For unlimited access to IPE’s industry-leading market intelligence, comprising news, data and long-form content on European pensions and institutional investment.